Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
3
60%
Ph phase_1
1
20%
Ph not_applicable
1
20%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
N/A1 (20.0%)

Trials by Status

terminated120%
unknown120%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Efficacy of Magnesium Sulfate on Reducing Renal Colic in the Emergency Department

NCT03617289
completedphase_2

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

NCT02592798
terminatedphase_2

The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects

NCT02267317
completedphase_1

Thiamine as a Metabolic Resuscitator in Septic Shock

NCT01070810
unknownphase_2

Paracetamol and Patent Ductus Arteriosus (PDA)

NCT01291654

Clinical Trials (5)

Showing 5 of 5 trials
NCT03617289Not Applicable

Efficacy of Magnesium Sulfate on Reducing Renal Colic in the Emergency Department

Completed
NCT02592798Phase 2

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Completed
NCT02267317Phase 2

The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects

Terminated
NCT01070810Phase 1

Thiamine as a Metabolic Resuscitator in Septic Shock

Completed
NCT01291654Phase 2

Paracetamol and Patent Ductus Arteriosus (PDA)

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5